Point72 Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.8M Sell
515,968
-460,084
-47% -$16.7M 0.04% 439
2025
Q1
$35.3M Sell
976,052
-206,825
-17% -$7.49M 0.08% 272
2024
Q4
$49.8M Buy
1,182,877
+529,217
+81% +$22.3M 0.11% 204
2024
Q3
$36.3M Buy
653,660
+113,911
+21% +$6.33M 0.09% 237
2024
Q2
$22.2M Buy
539,749
+478,849
+786% +$19.7M 0.06% 336
2024
Q1
$2.84M Sell
60,900
-41,600
-41% -$1.94M 0.01% 817
2023
Q4
$4.9M Sell
102,500
-613,962
-86% -$29.4M 0.01% 732
2023
Q3
$25.5M Buy
716,462
+291,588
+69% +$10.4M 0.07% 311
2023
Q2
$19.6M Sell
424,874
-961,987
-69% -$44.4M 0.06% 358
2023
Q1
$55.6M Buy
1,386,861
+659,174
+91% +$26.4M 0.17% 144
2022
Q4
$33.7M Buy
727,687
+377,000
+108% +$17.5M 0.11% 219
2022
Q3
$14.5M Buy
350,687
+77,172
+28% +$3.2M 0.06% 386
2022
Q2
$16.3M Sell
273,515
-44,982
-14% -$2.68M 0.07% 345
2022
Q1
$23.1M Sell
318,497
-107,377
-25% -$7.8M 0.09% 269
2021
Q4
$35.8M Buy
425,874
+85,500
+25% +$7.19M 0.14% 191
2021
Q3
$30.7M Sell
340,374
-366,926
-52% -$33.1M 0.13% 195
2021
Q2
$67.4M Buy
707,300
+587,700
+491% +$56M 0.3% 69
2021
Q1
$13.6M Sell
119,600
-100
-0.1% -$11.4K 0.06% 340
2020
Q4
$16.6M Buy
+119,700
New +$16.6M 0.08% 305
2020
Q1
Sell
-117,496
Closed -$5.02M 986
2019
Q4
$5.02M Buy
117,496
+61,680
+111% +$2.63M 0.03% 465
2019
Q3
$2.39M Buy
55,816
+21,553
+63% +$922K 0.01% 521
2019
Q2
$2.18M Buy
+34,263
New +$2.18M 0.01% 562
2019
Q1
Sell
-173,700
Closed -$7.55M 1072
2018
Q4
$7.55M Buy
173,700
+138,700
+396% +$6.03M 0.04% 401
2018
Q3
$2.67M Sell
35,000
-25,000
-42% -$1.91M 0.01% 581
2018
Q2
$4.61M Sell
60,000
-10,000
-14% -$769K 0.02% 501
2018
Q1
$3.57M Sell
70,000
-23,400
-25% -$1.19M 0.01% 518
2017
Q4
$4.33M Buy
93,400
+43,400
+87% +$2.01M 0.02% 509
2017
Q3
$2.66M Sell
50,000
-15,000
-23% -$799K 0.01% 528
2017
Q2
$4.04M Sell
65,000
-15,000
-19% -$932K 0.02% 463
2017
Q1
$5.42M Buy
+80,000
New +$5.42M 0.03% 465